Albert David Limited

NSE ALBERTDAVD.NS

Albert David Limited Capital Expenditure for the year ending March 31, 2024: USD -1.30 M

Albert David Limited Capital Expenditure is USD -1.30 M for the year ending March 31, 2024, a -104.60% change year over year. Capital expenditure is cash spent on acquiring or maintaining fixed assets, such as property, plants, and equipment (PP&E).

Albert David Limited Capital Expenditure for the year ending March 31, 2023 was USD -637.17 K, a 56.34% change year over year.
Albert David Limited Capital Expenditure for the year ending March 31, 2022 was USD -1.46 M, a -554.75% change year over year.
Albert David Limited Capital Expenditure for the year ending March 31, 2021 was USD -222.90 K, a 89.11% change year over year.
Albert David Limited Capital Expenditure for the year ending March 31, 2020 was USD -2.05 M, a -625.64% change year over year.

Key data

Date	Capital Expenditure	Free Cash Flow	Depreciation And Amortization	Deferred Income Tax

NSE: ALBERTDAVD.NS

Albert David Limited

CEO	Mr. Umesh Manohar Kunte
IPO Date	June 14, 2016
Location	India
Headquarters	Gillander House
Employees	1,497
Sector	Consumers Staples
Industries Personal Care Cleaning Supplies Cosmetics Drugstores & Retail Pharmacies Eyewear Glass Pharmaceuticals Plastics

Description

Albert David Limited manufactures and trades in pharmaceutical formulations, infusion solutions, herbal dosage forms, bulk drugs, and disposable syringes and needles in India. It offers formulations for parenterals, oral/enteral, topical agents, and vision care products. The company also exports its products to Latin American, Southeast Asian, and other African countries. The company was incorporated in 1938 and is headquartered in Kolkata, India.

Key trends

Past 5 years